Johnson & Johnson stock outperforms competitors despite losses on the day


Share on facebook
Share on twitter
Share on linkedin

Shares of Johnson & Johnson JNJ, -0.19% shed 0.19% to $160.47 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX, -1.48% falling 1.48% to 3,915.46 and Dow Jones Industrial Average DJIA, -0.46% falling 0.46% to 32,862.30. This was the stock’s second consecutive day of losses. Johnson & Johnson closed $13.18 below its 52-week high ($173.65), which the company reached on January 26th.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Roche Holding AG Part. Cert. RHHVF, -3.08% fell 3.08% to $330.24, Merck & Co. Inc. MRK, -0.04% fell 0.04% to $77.27, and Pfizer Inc. PFE, -0.06% fell 0.06% to $35.77. Trading volume (4.8 M) remained 3.4 million below its 50-day average volume of 8.1 M.